---

JULY 10TH

ASSISTANT FOOTBALL COACHES NEEDED

If anyone knows of anyone interested in being an assistant football coach, please feel free to contact Tony Miller at 647-6942.

SENIOR FOOTBALL AT ELMORE PARK

Elmore Park will have a Senior Football team this coming 2007 Football Season

Coaches are in place, uniforms have been ordered and everything is set to go. If you are a 7th or 8th grader that will not turn 14 prior to Sept. 30th you are eligible to play for the Pack.

There are a lot of advantages to playing 7th and 8th grade football at Elmore Park.



Here Are Just A Few:

1. A 8 game schedule with a 3 rounds of playoffs: Other leagues only have 5 or 6 games.

2. No year round practices: You begin practice in late July and the season is over the 2nd week in November.

3. Squad Size Is Smaller: Because squad size is smaller you get the chance to hone your skills and get more playing time.

4.Low Cost: Yeah some say they are free to play but pack on extra charges once you start. We tell you what its going to cost and thats it.

5.Not getting Defined By The High School Coaches: By playing in the other league the high school coaches may decide where you are going to play early as the 7th or 8th grade. With SYS you get the chance to develop at your own pace, still have fun and try a lot of positions. You might not get this chance with the other league.

6.Eligible for SYS Scholarship Moneys: If you participate with SYS you are automatically eligible for participation in SYS's Scholarship Program.

8.Learn the Fundamentals that will allow you to play at the High School Level: Many of our former participants have gone on to sucessfull high-school football careers. Just ask our coaches......

FIRST DAY OF PRACTICE SET FOR FOOTBALL AND CHEER

First day of practice will be on Monday, July 23rd from 6-7:30 pm at Kate Bond. Practice schedule will be Mon, Tues, Thurs, and Fri, 6-7:30 pm each day, REMEMBER....no pads the first week.

Cheer practice will begin the end of July first week of August....more on cheer practice dates and times as the season approaches....SEE YOU SOON!!!!

FOOTBALL AND CHEERLEADING SIGN-UPS CONTINUE..........

Come join the Elmore Park Packers for our 40th Football & Cheer Season




If you are a past Elmore Park participant and plan on playing this year, you need to make plans to sign-up at one of the upcoming sign-up dates.

Turn-out for the 07 season sign-ups has been great so the jersey number you want may not be available if you wait too long.We are also asking our players and cheerleaders to buddy up and bring a friend to come and be a part of our program

Football and Cheerleading sign-ups will continue, July 7th, 14th, and 21st from 12-2 p.m. at Milanos Pizza. New pariticipants will need to bring a recent picture and a copy of the birth certificate.


Milanos is located at 7625 US Highway 64, Bartlett,TN 38133.

CBHS FOOTBALL CAMP:::: GREAT LITTLE CAMP EXPERIENCE

CBHS is holding its 9th annual football camp. This is a great little camp. Positive, upbeat, great coaches and staff and just long enough to break a sweat in the mid-summer heat.

The camp is broken out into 2 sessions:

Grades-7,8,9 will be from July 16th-19th

Grades- 3,4,5,6 will be from July 23rd-26th.

Cost is $90

For more information click this link:

http://www.cbhs.org/athletics/camps/FootballCamp.pdf

CONGRATS TO OUR COACHES AND PARTICIPANTS

Congratulations to our 07 Track Team and all of our Coaches. You turned in an over the top off the chart performance setting records, winning medals, making numerous top 6 finishes and winning the Medium School Divison.

Matter of fact, you were so good that in spite of small numbers only 3 other programs out of the 15 in SYS scored higher than EPP in total points count...

The total Medal and Ribbon Count stands at 52. Placing in that many events is almost unheard of. The total Medal Count stands 30 with 12 Gold, 10 Silver and 8 Bronze.


SYS Record setting performances include the following teams:


8-9 Girls 3200 Meter Team


8-9 Girls 1600 Meter Team


8-9 Girls 800m Medly

You can check out these performances by visiting us on the web at www.elmoreparkapckers.com and clicking the Track Records link.

THANKS TO ALL OF OUR VOLUNTEERS ESPECIALLY OUR BOOSTER CLUB FOR MAKING THE 07 TRACK SEASON ONE OF THE BEST ON RECORD!!!!

FIRST TRACK PRACTICE WILL BE HELD AT ELMORE PARK MIDDLE SCHOOL

Mark your calendars. EPPs first Track & Field practice is scheduled for Monday March 5th at Elmore Park Middle and will run from 5.30p - 7p. The first few weeks of practice are scheduled to be held Mon,Tues,Thurs at Elmore Park Middle and at Bolton High School from 1p - 3p on Saturdays



Elmore Park Middle is located at 6330 Althorne in Bartlett. For directions you can visit us a the Elmore Park Homepage and click the Football Locations Links. Directions to Bolton High School can be found on the Track & Field Meet Locations link at the Elmore Park homepage.

HAVING A SAFE TRACK & FIELD SEASON

SYS now requires anyone being treated by a physician to get a medical release. The SYS Medical Release Form can now be found at the Forms Link at the Elmore Park Homepage.


This requirement is specific to anyone being treated for asthama. Any other participants who are being treated for ADD or ADHD and are being prescribed the current line of medications used to treat this condition may want to consider seeking a physical and medical release.


The article below covers the upcoming Black Box warning that is soon to be required on many of the ADD and ADHD medications currently in use.


Advisers Want Black-Box Warning for ADHD Drugs

Donna Young



GAITHERSBURG, MD, 10 February 2006 — In an unexpected move that appeared to stun drug regulators, a federal advisory panel yesterday voted 8–7 to add a black-box warning to the labeling of stimulants used to treat attention-deficit/hyperactivity disorder (ADHD) to alert prescribers about cardiovascular risks associated with use of the drugs.



The Drug Safety and Risk Management Advisory Committee also voted in favor of requiring makers of ADHD stimulants to develop medication guides, which pharmacists would distribute when dispensing the medications, to inform patients about cardiovascular risks in ADHD medication use.



Panelists decided to exclude from the vote the ADHD medication atomoxetine, or Strattera, which is a selective norepinephrine-reuptake inhibitor made by Eli Lilly and Co.



The advisers were most concerned about the known effects of sympathomimetic drugs on blood pressure, coronary artery disease, and structural cardiac abnormalities.



The Food and Drug Administration (FDA) has received reports of more than 20 deaths associated with use of ADHD drugs, reviewers said.



But, said Kate Gelperin, a medical officer in FDA's Office of Drug Safety, cardiovascular signals in ADHD adverse events reported to the agency were "not conclusive."



About 1.5 million adults and 2.5 million children take ADHD medications, FDA safety reviewers told the panel.



Use of ADHD medications is on the rise, especially in adults, said Andrew Mosholder, a medical officer in FDA's Office of Drug Safety.



There was a 90 percent increase in adult use of the drugs over the past three years, he told the advisers. About 10 percent of adult users of ADHD medications are over age 50, Mosholder added.



ADHD medication use in children peaks around ages 9–12, and then drops off, he said.



Methylphenidate products, marketed by Novartis under the brand name Ritalin, are the most frequently prescribed ADHD medications, Mosholder said.



"Over the last decade or so, we've seen an enormous rise in the use of these drugs now to the point that 10 percent of 10 year olds are getting treated" for ADHD, said Steven Nissen, director of cardiovascular medicine at the Cleveland Clinic in Ohio—the panelist who proposed the black-box vote. "I have grave concerns about the direction we are going in with the mass use of these drugs and the potential for harm," he said.



Regulators had not planned a vote at yesterday's advisory committee meeting, which was convened to discuss approaches for studying ADHD drugs and cardiovascular risks.



"We specifically sought this committee's advice on how to design a study that's going to help us better define cardiovascular risks," said Tom Laughren, director of FDA's Division of Psychiatry Products. "We desperately need to try and figure out a way to systematically confirm whether or not there is a risk. I don't think we're there yet for a black box."



ADHD medications approved for marketing in the United States already include warnings in product labeling that caution prescribers about treating patients with underlying medical conditions that might be compromised by increases in blood pressure or heart rate, he said.



Amphetamine salts, marketed by Shire as Adderall, and the company's extended-release form of the drug, Adderall XR, include warnings about reports of sudden death in children with structural cardiac abnormalities, Laughren said. The labeling warns that amphetamine salts should not be used in children or adults with structural cardiac abnormalities, he added.



"We've more recently asked all the other stimulant manufacturers to add similar language to the warning section of their labels so that all of the stimulant drugs, at least, will have consistent language," Laughren said.



But, he cautioned, "this is not a contraindication....It's an alert to clinicians to pay attention to both the effects that slight raises in blood pressure or heart rate might have on patients with underlying disorders, and to be cautious. We feel that this language is appropriate given our current level of knowledge about these drugs."



Laughren told the drug safety panel that FDA reserves the black box—the agency's strongest warning—for "risk that is very clearly established as causal."



"I don't think we are there yet with this cardiovascular risk," he said.



But Curt D. Furberg, professor of medicine at Wake Forest University in Winston-Salem, N.C., argued that the warnings and precautions section of drug labeling has little impact on prescribing.



"In order to get a message across to physicians and patients, you need to step it up a bit," he said. "I agree that we don't have final information on harm. But sometimes what's missing in the labeling is a statement that these drugs may have a harmful effect, there's incomplete information, and advise caution. I think it would be reasonable to elevate the warning to the public and add a black box to it."



Henri R. Manasse Jr., executive vice president for the American Society of Health-System Pharmacists, said he voted in favor of the black-box warning because "I think this is a serious issue related to the practice behavior both for pharmacists and physicians, and I think the only way we are going to get the attention of the medical community and the pharmacy community in sharing with patients what the potential risks are with these medications is through the black-box warning."



Nissen expressed similar sentiments.



"The only way you get people to pay attention is when you put [warnings] in a black box," he said. "It just doesn't seem to get there if you don't do something pretty dramatic. I want to cause people's hands to tremble a little bit before they write that script. And the only way I know to do that is to get their attention with a black box. That's the reality."



Laughren reminded the panel of drug safety experts that the agency's Pediatric Advisory Committee, whom regulators, at a press conference held late yesterday, described as more familiar with ADHD pediatric patients, plans to meet on March 22 to discuss the medications. The Psychopharmacologic Drugs Advisory Committee plans to meet on March 23 to discuss modafinil, which is under review for marketing approval to treat ADHD.



"So this is not the only opportunity for an outside group to give the FDA advice about what to do with labeling," Laughren said.



But panelist Arthur Levin, director of the Center for Medical Consumers, charged that "for us to sit around and talk about this, to have three advisory committee meetings discussing the signals and not to make at the very least a very strong warning to people that there is uncertainty here about the safety of these drugs and that they need to be aware of that pending clarification, I just think is inappropriate, unethical behavior."

TRACK & FIELD SIGN-UPS: A NOTE FROM OUR BOOSTER CLUB

 

 

TRACK & FIELD SIGN-UPS

ELMORE PARK'S MASCOT: GONE BUT NOT FORGOTTON